Results 141 to 150 of about 56,772 (310)
ABSTRACT Autistic youth exhibit wide variability in emotional and behavioral challenges, yet few studies have identified meaningful subgroups based on these profiles. This study applied a random forests ensemble clustering algorithm to item‐level parent‐report data from the Emotion Dysregulation Inventory (EDI) and the Child Behavior Checklist (CBCL ...
Safaa Eldeeb +6 more
wiley +1 more source
Men and heart disease : an atlas of racial and ethnic disparities in mortality [PDF]
Developed by the Office for Social Environment and Health Research at West Virginia University and the Cardiovascular Health Branch at CDC to provide critical data on geographic, racial, and ethnic inequalities in men's heart disease death rates for the ...
core
Background and Purpose Although opioids are central to end of life (EoL) care, tissue‐level opioid exposure remains poorly understood. The objective of this study was to characterize the relationship between prescription‐derived morphine equivalent daily dose (MEDD) and measured morphine concentrations across multiple organs.
Niamh Higgins +23 more
wiley +1 more source
Racial/Ethnic and Education-Related Disparities in Control of Risk Factors for Cardiovascular Disease among Diabetics [PDF]
Objectives: To estimate racial/ethnic and education-related disparities and examine trends in uncontrolled cardiovascular (CVD) risk factors among adults with diabetes.Methods: The analysis samples include adults aged 20 and over from NHANES III, 1988 ...
Heesoo Joo +2 more
core
Aim To develop and validate a physiologically‐based pharmacokinetic (PBPK) model enabling inhaled oxytocin dose selection for clinical evaluation. Subsequently, to conduct a phase 1 study investigating the pharmacokinetics and safety of selected doses of an optimized inhaled oxytocin product in healthy, non‐pregnant female participants.
Pete Lambert +6 more
wiley +1 more source
Aims The aim of this study is to evaluate the effects of multiple doses of esomeprazole, a strong proton pump inhibitor and acid‐reducing agent, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader.
Lana Tran +7 more
wiley +1 more source
Abstract Aims Canagliflozin was recently approved in type 2 diabetes mellitus (T2DM) patients ≥10 and <18 years old as a single agent dosed once daily (QD) or in a fixed‐dose combination with metformin dosed twice daily (BID). We characterize canagliflozin pharmacokinetics in paediatric patients with T2DM, compare estimated individual and simulated ...
Nele Goeyvaerts +6 more
wiley +1 more source
Garth Graham Department of Medicine, University of Florida, Gainesville, FL, USA Abstract: This is a comprehensive narrative review of the literature on the current science and evidence of population-level differences in risk factors for heart disease ...
Graham G
doaj
Ethnic Inequality in Canada: Economic and Health Dimensions [PDF]
This study examines ethnic based differences in economic and health status. We combine existing literature with our analysis of data from the Canadian Census and National Population Health Survey. If a given sub-topic is well researched, we summarize the
Ellen M. Gee +2 more
core
Abstract In early childhood education many researchers and professionals across the world have embraced the United Nations Convention on the Rights of the Child's requirement to include young children in decision‐making. In the context of ongoing discussion about young children's capacity to share their views and opinions about matters affecting them ...
Laura Lundy +3 more
wiley +1 more source

